Clearside Biomedical (NASDAQ: CLSD) is owned by 13.68% institutional shareholders, 42.22% Clearside Biomedical insiders, and 44.11% retail investors. Clay Thorp is the largest individual Clearside Biomedical shareholder, owning 7.02M shares representing 11.32% of the company. Clay Thorp's Clearside Biomedical shares are currently valued at $6.11M.
If you're new to stock investing, here's how to buy Clearside Biomedical stock.